Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hazem El-Osta

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|March 16, 2013
Rituximab-induced acute thrombocytopenia: an underappreciated entityHazem El-Osta, Binu Nair
Pharmacogenomics and Personalized Medicine|December 2, 2015
Personalized treatment options for ALK-positive metastatic non-small-cell lung cancer: potential role for CeritinibHazem El-Osta, Rodney Shackelford
Immunotherapy|February 8, 2019
Predictors for clinical benefit of immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysisHazem El-Osta, Syed Jafri
Annals of Internal Medicine|February 5, 2009
Delayed splenic rupture: myth or reality?Hazem El-Osta, William J Salyers
Molecular Cancer Therapeutics|May 27, 2010
Successful treatment of Castleman's disease with interleukin-1 receptor antagonist (Anakinra)Hazem El-Osta, Filip Janku, Razelle Kurzrock
Translational Lung Cancer Research|May 18, 2016
Epigenetics in non-small cell lung cancer: from basics to therapeuticsJunaid Ansari, Rodney E Shackelford, Hazem El-Osta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Lung carcinoma associated with excessive eosinophiliaHazem El-Osta, Peter El-Haddad, Nassim Nabbout
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 22, 2009
Acquired factor VIII inhibitors: case reports of paclitaxel and penicillin-induced entitiesHazem El-Osta, Pavan Reddy, Jeremy M Deutsch
Le Journal Medical Libanais. the Lebanese Medical Journal|May 31, 2018
Benefits and potential risks of bisphosphonate therapy A narrative reviewLana El Osta, Nada El Osta, Hazem El Osta
Oncotargets and Therapy|August 31, 2016
Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatmentHazem El-Osta, Kamran Shahid, Glenn M Mills, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|March 16, 2013
Rituximab-induced acute thrombocytopenia: an underappreciated entityHazem El-Osta, Binu Nair
Pharmacogenomics and Personalized Medicine|December 2, 2015
Personalized treatment options for ALK-positive metastatic non-small-cell lung cancer: potential role for CeritinibHazem El-Osta, Rodney Shackelford
Immunotherapy|February 8, 2019
Predictors for clinical benefit of immune checkpoint inhibitors in advanced non-small-cell lung cancer: a meta-analysisHazem El-Osta, Syed Jafri
Annals of Internal Medicine|February 5, 2009
Delayed splenic rupture: myth or reality?Hazem El-Osta, William J Salyers
Molecular Cancer Therapeutics|May 27, 2010
Successful treatment of Castleman's disease with interleukin-1 receptor antagonist (Anakinra)Hazem El-Osta, Filip Janku, Razelle Kurzrock
Translational Lung Cancer Research|May 18, 2016
Epigenetics in non-small cell lung cancer: from basics to therapeuticsJunaid Ansari, Rodney E Shackelford, Hazem El-Osta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Lung carcinoma associated with excessive eosinophiliaHazem El-Osta, Peter El-Haddad, Nassim Nabbout
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 22, 2009
Acquired factor VIII inhibitors: case reports of paclitaxel and penicillin-induced entitiesHazem El-Osta, Pavan Reddy, Jeremy M Deutsch
Le Journal Medical Libanais. the Lebanese Medical Journal|May 31, 2018
Benefits and potential risks of bisphosphonate therapy A narrative reviewLana El Osta, Nada El Osta, Hazem El Osta
Oncotargets and Therapy|August 31, 2016
Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatmentHazem El-Osta, Kamran Shahid, Glenn M Mills, et al.
Pageof 3